
Paracetamol (325mg) + Mefenamic Acid (500mg)
Active composition
+1 more active ingredient
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Mefenamic acid inhibits cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Medical applications
The Nipramef-P Tablet is a combined analgesic and antipyretic medication, containing Mefenamic Acid (500mg) and Paracetamol (325mg) per tablet. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), is effective for treating pain and inflammation, while Paracetamol acts as an analgesic and antipyretic agent, reducing fever and alleviating pain. This combination offers comprehensive relief from various aches, pains, and fever, making it an effective choice for managing a wide range of symptomatic conditions. Always consult a healthcare provider for proper dosage and usage instructions, as the safe and effective use of this medication requires professional medical supervision.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nipramef-P Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nipramef-P Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Medical Advice
Nipramef-P Tablet should be used with caution in patients with kidney disease. Dose adjustment of Nipramef-P Tablet may be needed. Please consult your doctor. Use of Nipramef-P Tablet is not recommended in patients with severe kidney disease.
Exercise Caution
Nipramef-P Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nipramef-P Tablet should be used with caution in patients with liver disease. Dose adjustment of Nipramef-P Tablet may be needed. Please consult your doctor. However, the use of Nipramef-P Tablet is not recommended in patients with severe liver disease and active liver disease.
Regular Checkup
0 reviews for Nipramef-P Tablet

Mefenamic Acid (500mg) + Paracetamol (325mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Mefenamic acid inhibits cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Medical applications
The Nipramef-P Tablet is a combined analgesic and antipyretic medication, containing Mefenamic Acid (500mg) and Paracetamol (325mg) per tablet. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), is effective for treating pain and inflammation, while Paracetamol acts as an analgesic and antipyretic agent, reducing fever and alleviating pain. This combination offers comprehensive relief from various aches, pains, and fever, making it an effective choice for managing a wide range of symptomatic conditions. Always consult a healthcare provider for proper dosage and usage instructions, as the safe and effective use of this medication requires professional medical supervision.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nipramef-P Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nipramef-P Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Medical Advice
Nipramef-P Tablet should be used with caution in patients with kidney disease. Dose adjustment of Nipramef-P Tablet may be needed. Please consult your doctor. Use of Nipramef-P Tablet is not recommended in patients with severe kidney disease.
Exercise Caution
Nipramef-P Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nipramef-P Tablet should be used with caution in patients with liver disease. Dose adjustment of Nipramef-P Tablet may be needed. Please consult your doctor. However, the use of Nipramef-P Tablet is not recommended in patients with severe liver disease and active liver disease.
Regular Checkup
0 reviews for Nipramef-P Tablet













